Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study [Vascular Medicine]

ConclusionsEndothelial function is improved by tocilizumab in a high‐risk population, even as it increases total cholesterol and low‐density lipoprotein levels.

Source: JAHA:Journal of the American Heart Association - March 13, 2017 Category: Cardiology Authors: Bacchiega, B. C., Bacchiega, A. B., Usnayo, M. J. G., Bedirian, R., Singh, G., Pinheiro, G. d. R. C. Tags: Endothelium/Vascular Type/Nitric Oxide, Inflammation, Atherosclerosis, Coronary Artery Disease Original Research Source Type: research